Consensus Enovis Corporation

Stocks

ENOV

US1940145022

Medical Equipment, Supplies & Distribution

Market Closed - NYSE 21:00:02 28/08/2026 BST			5-day change	1st Jan Change
24.90 ^USD	+0.28%		-4.89%	-6.53%

08-06	Enovis Shares Fall After Fiscal Q2 Results	MT
08-06	Enovis Corporation, Q2 2026 Earnings Call, Aug 06, 2026

Evolution of the Average Target: Enovis Corporation

Evolution of the Target Price: Enovis Corporation

Changes in Analyst Recommendations: Enovis Corporation

5ff8f92b3feb0d953ffb63a5b527.exAyUJIPTh7DsAKFB4IBY4KJsPe6qYamru7WKoK99jE.P2lbfc11ASylyGTNXu1WDLGk09rr2MfK6aizT_vEgXBIe1QCp0p4UrfhUw~d1dc09d9ea27d89be2d4ea489ef3990d

Analysts' recommendations: Enovis Corporation

07-28	UBS Adjusts Price Target on Enovis to $51 From $50, Maintains Buy Rating	MT
07-09	BMO Capital Initiates Enovis at Outperform With $29 Price Target	MT
02-27	Needham Raises Price Target on Enovis to $52 From $49, Keeps Buy Rating	MT
01-06	BTIG Initiates Enovis at Buy With $41 Price Target	MT
08/08/25	Needham Cuts Price Target on Enovis to $49 From $57, Keeps Buy Rating	MT
08/08/25	UBS Adjusts Enovis Price Target to $57 From $65, Maintains Buy Rating	MT
12/05/25	UBS Adjusts Price Target on Enovis to $65 From $75, Maintains Buy Rating	MT
03/10/24	JMP Securities Initiates Enovis at Outperform With $62 Price Target	MT
08/08/24	Needham Adjusts Price Target on Enovis to $65 From $82, Maintains Buy Rating	MT
13/06/24	JPMorgan Initiates Enovis at Neutral With $53 Price Target	MT
23/02/24	Canaccord Genuity Ups Price Target on Enovis to $75 From $73, Maintains Buy Rating	MT
23/02/24	Needham Raises Price Target on Enovis to $82 From $73, Maintains Buy Rating	MT
13/02/24	Stephens Initiates Enovis With Overweight Rating, $72 Price Target	MT
22/01/24	UBS Initiates Coverage on Enovis With Buy Rating, $75 Price Target	MT
03/01/24	William Blair Initiates Enovis at Outperform Rating	MT
20/12/23	Canaccord Genuity Adjusts Enovis Price Target to $71 From $65, Maintains Buy Rating	MT
15/12/23	Needham Adjusts Price Target on Enovis to $70 From $62, Keeps Buy Rating	MT
04/08/23	Baird Adjusts Price Target on Enovis to $70 From $67, Maintains Outperform Rating	MT
26/06/23	Needham Initiates Enovis With Buy Rating, $70 Price Target	MT
12/05/23	Wells Fargo Upgrades Enovis to Overweight Rating From Equal Weight, Adjusts Price Target to $67 From $55	MT
24/02/23	Baird Adjusts Enovis Price Target to $64 From $68, Maintains Outperform Rating	MT
03/11/22	Baird Adjusts Enovis' Price Target to $68 From $73, Keeps Outperform Rating	MT
26/10/22	Wells Fargo Lowers Enovis' Price Target to $53 From $60, Keeps Equalweight Rating	MT
12/10/22	Jefferies Initiates Enovis at Buy with $60 Price Target	MT
11/10/22	Goldman Sachs Initiates Coverage on Enovis With Buy Rating, $57 Price Target	MT

More recommendations

Medical Devices & Implants

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
ENOVIS CORPORATION			+64.45%
STRYKER CORPORATION			+18.81%
SMITH & NEPHEW PLC			+19.12%
GLAUKOS CORPORATION			+8.38%
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.			+43.95%
DOUBLE MEDICAL TECHNOLOGY INC.	-	-	+14.61%
INSPIRE MEDICAL SYSTEMS, INC.			-0.69%
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.			+40.08%
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-	-	-
Average			+26.09%
Weighted average by Cap.			+19.14%